Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma

Cancer

Volumn 78, Issue 11, 1996, Pages 2379-2387

  Gohji, Kazuo ^a,b,e   Fujimoto, Noboru ^c   Komiyama, Toyozo ^a   Fujii, Akio ^a   Ohkawa, Jiro ^a   Kamidono, Sadao ^b   Nakajima, Motowo ^d  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^d CIBA GEIGY LTD   (Switzerland)

^e Department of Urology ^*  (Japan)

Author keywords

matrix metalloproteinase 2; matrix metalloproteinase 3; recurrence; urothelial carcinoma

Indexed keywords

CISPLATIN; GELATINASE; STROMELYSIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLOOD LEVEL; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA; CONTROLLED STUDY; CYSTECTOMY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; PREDICTION; PRIORITY JOURNAL; UROTHELIUM;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; GELATINASES; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0029845841     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961201)78:11<2379::AID-CNCR17>3.0.CO;2-Y     Document Type: Article

References (24)

1. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eight G.H.A. Clowes Memorial Award Lecture. Cancer Res 1990;50:6130-8.
2. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980;283:139-46.
3. Nakajima M, Chop AM. Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Semin Cancer Biol 1991;2:115-27.
4. Liotta LA, Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Semin Cancer Biol 1990; 1:99-106.
5. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. Influence of organ environment on the growth, selection and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988; 48:6863-71.
6. Nakajima M, Welch DR, Belloni PN, Nicolson GL. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987;47: 4869-76.
7. Gohji K, Nakajima M, Dinney CPN, Fan D, Pathak S, Killion JJ, et al. The importance of orthotopic implantation to the isolation and biological characterization of a metastatic human clear cell renal carcinoma in nude mice. Int J Oncol 1993;2:23-32.
8. Gohji K, Nakajima M, Fabra A, Bucana CD, von Eschenbach AC, Tsuruo T, et al. Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibro blasts. Jpn J Cancer Res 1994;85:152-60.
9. Matrisian LM, Bowden GT. Stromelysin/transin and tumor progression. Semin Cancer Biol 1990;1:107-15.
10. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103.
11. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, et al. A one-step sandwich enzyme immunoassay for human matrix matalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
12. Nakajima M, Welch DR, Wynn DM, Tsuruo T, Nicolson GL. Serum and plasma Mr 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res 1993;53:5802-7.
13. Garbisa S, Scagliotti G, Masiero L, Francesco CD, Caenazzo C, Onisto M, et al. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res 1992;52:4548-9.
14. Beathrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging of cancer. 4th edition. Philadelphia: J.B. Lippincott Co., 1992.
15. Okada Y, Harris ED Jr, Nagase H. The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem J 1988;254:731-41.
16. Cox DR. Regression models and life table. J R Stat Soc (B) 1972;34:187-220.
17. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991;145:459-67.
18. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991; 145:45-50.
19. Brown PD, Bloxidge RE, Stuart NSA, Gatter KC, Carmichael J. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 1993;85:574-8.
20. Zucker S, Lysik RM, Zarrabi MH, Moll U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993;53:140-6.
21. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, et al. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 1993; 53:5365-9.
22. Stóckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, et al. Adjuvant polychemotherapy of non-organ-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 1995; 153:47-52.
23. Malkowicz SB, Nichols P, Lieskovsky G, Boyd SD, Huffman J, Skinner DG. The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 1990; 144:641-5.
24. Stóckle M, Alken P, Engelmann U, Jacobi GH, Reidmiller H, Hohenfellner R. Radikale Zystektomie-oft zu spat? Aktuel Urol 1986; 17:234-9.